Novel potent antagonists of human neuropeptide YY5 receptors. Part 3: 7-methoxy-1-hydroxy-1-substituted tetraline derivative

被引:18
作者
Itani, H
Ito, H
Sakata, Y
Hatakeyama, Y
Oohashi, H
Satoh, Y
机构
[1] Fujisawa Pharmaceut Co Ltd, Med Chem Res Labs, Yodogawa Ku, Osaka 5328514, Japan
[2] Fujisawa Pharmaceut Co Ltd, Med Biol Res Labs, Yodogawa Ku, Osaka 5328514, Japan
关键词
D O I
10.1016/S0960-894X(02)00018-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As a part of our continuing research on NPY-Y5 receptor antagonists in the series of novel 6-methoxybenzo[a]cycloheptene derivatives, we discovered a novel skeleton, 7-methoxy-1-hydroxytetraline 7 which had been used as an intermediate, to be more suitable for increasing potencies leading to compound 3 (FR230481). Additionally. we discovered that the naphthalenesulfonamide moiety which was thought to be an essential pharmacophore could be replaced by the 5-chlorobenzothiazolin-3-acetic acid moiety to lead to potent compound 4 (FR233118). The structure-activity relationships on compounds 3, 4 and their related derivatives are described. Unfortunately. although compounds 3 and 4 had very high affinities for Y5 receptors, their poor permeabilities to brain were shown by exo-vivo binding assays when orally administered. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:799 / 802
页数:4
相关论文
共 13 条
[1]  
BECK B, 1992, INT J OBESITY, V16, P295
[2]   A receptor subtype involved in neuropeptide-Y-induced food intake [J].
Gerald, C ;
Walker, MW ;
Criscione, L ;
Gustafson, EL ;
BatzlHartmann, C ;
Smith, KE ;
Vaysse, P ;
Durkin, MM ;
Laz, TM ;
Linemeyer, DL ;
Schaffhauser, AO ;
Whitebread, S ;
Hofbauer, KG ;
Taber, RI ;
Branchek, TA ;
Weinshank, RL .
NATURE, 1996, 382 (6587) :168-171
[3]  
HOFBAUER KG, 1997, REGUL PEPTIDES, V71, P211
[4]   Neuropeptide Y feeding receptors: are multiple subtypes involved? [J].
Inui, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (02) :43-46
[5]   Novel potent antagonists of human neuropeptide YY5 receptors.: Part 2:: Substituted benzo[α]cycloheptene derivatives [J].
Itani, H ;
Ito, H ;
Sakata, I ;
Hatakeyama, Y ;
Oohashi, H ;
Satoh, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) :757-761
[6]  
KALRA SP, 1992, PHYSIOL BEHAV, V50, P5
[7]   Y-1 AND Y-2 RECEPTOR-SELECTIVE NEUROPEPTIDE-Y ANALOGS - EVIDENCE FOR A Y-1 RECEPTOR SUBCLASS [J].
KIRBY, DA ;
KOERBER, SC ;
MAY, JM ;
HAGAMAN, C ;
CULLEN, MJ ;
PELLEYMOUNTER, MA ;
RIVIER, JE .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (22) :4579-4586
[8]  
RUGER H, 1997, Patent No. 9720823
[9]   NEUROPEPTIDE-Y INJECTED IN THE PARAVENTRICULAR HYPOTHALAMUS - A POWERFUL STIMULANT OF FEEDING-BEHAVIOR [J].
STANLEY, BG ;
LEIBOWITZ, SF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) :3940-3943
[10]   EVIDENCE FOR NEUROPEPTIDE Y MEDIATION OF EATING PRODUCED BY FOOD-DEPRIVATION AND FOR A VARIANT OF THE Y1-RECEPTOR MEDIATING THIS PEPTIDES EFFECT [J].
STANLEY, BG ;
MAGDALIN, W ;
SEIRAFI, A ;
NGUYEN, MM ;
LEIBOWITZ, SF .
PEPTIDES, 1992, 13 (03) :581-587